• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Use of a Disposable Radiation Protective Table for Reducing Operator Radiation Exposure during Cardiovascular Angiographic Proce

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 3757 reads
Author(s): 

Mitchell J. Silver, DO, Charles Botti, Jr, MD

Introduction
The use of fluoroscopic imaging continues to increase during medical procedures. Fluoroscopic imaging plays a fundamental role in the diagnostic and treatment of cardiac and vascular disease. The cumulative operator and/or staff occupational exposure from scatter radiation may be considerable.1 Cardiologists are the most common physician specialty with overexposure to radiation, and the number is felt to be grossly underreported.2 The risk of these exposures may not be appreciated by physicians because the adverse consequence is not immediate. Though occupational radiation exposure for health care personnel has long been felt to have a minimum threshold that is safe and acceptable, this hypothesis has been shown to be in error. Research shows that there is no threshold of exposure below which low levels can be demonstrated to be harmless or beneficial. The health risk, particularly the development of solid cancers rises proportionally with exposure. The Occupational Safety and Health Administration (OSHA) is re-evaluating the current guidelines for occupational exposure.3 It appears reasonable to assume with the recent release of the Biological Effects of Ionizing Radiation (BEIR VII) report that the guidelines for the principle of ALARA (as low as reasonably achievable) will be substantially strengthened.4 This study evaluates a new radiation protection device intended to reduce radiation exposure to health care workers during cardiovascular angiographic procedures.

Materials and Methods
Description of radiation shielding device. The radiation shielding device consisted of a fiber board table with a side layer of radiation absorbing material consisting of a polymer impregnated with barium equivalent to .25 inches of lead with dimensions of 80 cm by 12 cm. (The Protector, Vascular Performance Products, Caledonia, Michigan). The table is placed from knee to ankle and rests under the sterile drape acting as a equipment platform as well (Figure 1).

Physician and patient characteristics. This study was conducted from 3/25/05 to 4/12/05 in the cardiac catheterization laboratories at a large tertiary hospital. On average, over 14,000 angiographic procedures, which include over 1500 peripheral vascular procedures, are completed in this department each year. The catheterization staff undergoes annual continuing education on radiation exposure. All participating physicians are board certified in cardiology and annually perform more than 500 procedures.

The patient population included 50 patients referred for diagnostic left heart catheterization and underwent written informed consent. The patients mean age was 70.0 (± 12.1) years with 33 male and 17 female. Average body surface area was 2.0 cm2, with an average weight 94.3 ± 29.5 Kg and height 171.2 cm.
Fluoroscopic System and Radiation Measurement: Catheterizations and angiography were performed on single-plane angiographic systems (Integris V5000 and H 5000, Phillips, Eindhoven, Netherlands). The image intensifier was routinely set on 7 inch mode for coronary angiography and 9 inch for ventriculography considered standard in the cardiac community. Fluoroscopy was set to a pulsed mode of 7.5 frames per second. Recording angiography was recorded at a rate of 15 frames per second. Collimation was not utilized, however, the physicians were encouraged to utilize standard shielding available in the laboratory.

Catheterizations were routinely performed within a set of 7 angled views. For coronary evaluation this included left anterior oblique (LAO) caudal, LAO with cranial, straight anterior with cranial angulation, right anterior oblique (RAO) caudal and RAO with cranial angulation. Ventriculography was completed with straight RAO and LAO projections. Angles were optimized for the individual patient. The performing cardiologists were asked to wear 2 dosimeters (DMC 2000, Global Dosimetry Solutions Inc., Irvine, California) that utilized a silicon diode detector with a energy range of 50keV-6MeV and a linear response to 1000R/hr. The cardiologists wore the dosimeters on the outside of their sterile gowns at the level of mid-abdomen and outside the thyroid shield during the completion of angiographic procedures. These placement areas were chosen for their solid organs that may be most affected by radiation scatter (e.g., liver, kidneys, prostate, testicles and thyroid). The procedures were randomly assigned to either use of their standard of care, which included routine use of standard protection devices in the angiographic suite (Figure 2) or additional use of the radiation protection table (Figure 3). If the patients went on to interventional procedures, the dosimeters were removed at the end of the diagnostic angiographic procedure. Patient body surface area, radiation fluoroscopic, and cine angiography run times were recorded for analysis.

Statistical Analysis
All variables are given as a mean ± standard deviation. ANOVA was used to determine the significance level of differences in several parameters. A value of p < 0.05 was considered statistically significant. All statistical analyses were performed using Statview software, version 5.0.1 (SAS Institute Inc., Cary, North Carolina).

Results
Twenty-six patients were randomized to standard of care while 24 patients were randomized to the use of the radiation protection table. Twelve different cardiologists performed measured procedures with a frequency of 1–8 procedures. The average fluoroscopy times were similar between the control group 1.86 (± 1.27) minutes and the protected group 2.47 (± 1.90) minutes. The number of cine angiographic runs was also the same at 10.36 (± 2.86) and 10.29 (± 2.35), respectively.

References: 

1. Balter S. Radiation safety in the cardiac catheterization laboratory: Operational radiation safety. Catheter Cardiovasc Interv 1999;47:347–353.
2. Block CB, Bonchek LI, Brundage BH, et al. Use of radiographic devices by cardiologists. JACC 1995;25:1738–1739.
3. Mellinger Frank. US Department of Labor news release. http://osha.gov/pls/oshaweb/owadisp.show_document?p_table=NEWS_RELEASES.gov
4. Biological Effects of Ionizing Radiation (BEIR VII) study.
5. Matanoski GM, Sartwell P, Sewell P, et al. Cancer Risks in Radiologists and Radiation Workers. In: Boice JD Jr, Fraumeni JF Jr (eds). Radiation Carcinogenesis: Epidemiology and Biological Significance. New York: Raven 1984;83–96.
6. Broadbent MV, Hubbard LB. Science and perception of radiation risk. Radiographics 1992;12:381–392.
7. Hendee WR. Estimation of radiation risks: BEIR V and its significance for medicine. JAMA 1992;268:620–624.
8. Johnson LW, Moore RJ, Balter S. Review of radiation safety in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn 1992;25:186–194.
9. Niklason LT, Marx V, Chan HP. Interventional radiologists: Occupational radiation doses and risks. Invest Radiol 1987;22:747–750.
10. King JN, Champlin AM, Tripp CA, et al. Using a sterile disposable protective surgical drape for reduction of radiation exposure to interventionalists. AJR 2002;178;153–157.
11. Yaffe MW, Mawdsley GE, Lilley M, et al. Composite materials for X-ray protection. Health Phs 1991;60:661–664.
12. Young AT, Morin RL, Hunter DW, et al. Surface shield: Device to reduce personnel radiation exposure. Radiology 1986;159:801–803.
13. Miller DL, Vucich JJ, Cope C. Flexible shield to protect personnel during interventional procedures. Radiology 1985;155:825–826.

  • 1
  • 2
  • 3
  • next ›
  • last »
image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
  • Robotic-Assisted Pci Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference
    Tue, 02/07/12 - 10:00am
  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications